In serous ovarian cancer, Versican was reportedly expressed at significantly greater levels in tumor samples versus normal ovarian tissues.14 In our study, we first investigated altered Versican expression in 78 pairs of GC and ANT samples by RT–qPCR and confirmed that Versican expression was significantly greater in 78 GC tumor tissues relative to the respective ANT samples. This evidence concerns the gene VCAN and neoplasm.